An inhibitor of ppGalNAc-T3 was identified and found to block breast cancer cell invasiveness as well as secretion of intact FGF23 promising new therapeutic approaches for cancer and chronic kidney disease, respectively. The gene discussed is FGF23; the disease is cancer.